Podcast Episodes
Back to SearchLessons From The Bone Therapeutics/Medsenic Merger With BioSenic's François Rieger, Ph.D.
We love to hear from our listeners. Send us a message.
On the surface, the merger of Medsenic (a developer of arsenic salt formulations for therapeut…
2 years, 10 months ago
TCRs In Personalized Oncology With BlueSphere Bio's Keir Loiacono
We love to hear from our listeners. Send us a message.
Among a growing cluster of Pittsburgh biotechs, you'll find BlueSphere Bio, an early-stage com…
2 years, 10 months ago
BoB@JPM: Self-Replicating RNA With Elixirgen's Akihiro Ko
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BoB@JPM
Elixirgen Therapeutics CEO Akihiro Ko joins the Business of Biotech fo…
2 years, 10 months ago
BoB@JPM: Gene Writing With Tessera's Michael Severino, M.D.
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BOB@JPM
Flagship Pioneering plucked Michael Severino, M.D. away from AbbVie to…
2 years, 10 months ago
BoB@JPM: Post-IPO With Bolt Biotherapeutics' Drs. Randall Schatzman and Edith Perez
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BOB@JPM
Bolt Biotherapeutics CEO Randall Schatzman, Ph.D. and CMO Edith Perez,…
2 years, 10 months ago
BoB@JPM: Academia To Industry With Oncolytics' Matt Coffey, Ph.D.
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BoB@JPM
The JP Morgan Healthcare Conference is a target-rich environment for c…
2 years, 11 months ago
BoB@JPM: Support Of A Blossoming Pipeline With Sangamo's Sandy Macrae, Ph.D.
We love to hear from our listeners. Send us a message.
SPECIAL EDITION: BoB@JPM
The Business of Biotech podcast took to the streets of San Francisco d…
2 years, 11 months ago
Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
We love to hear from our listeners. Send us a message.
Is it past time for a new approach to the COVID vaccine? Ocugen Chairman of the Board, Founder…
2 years, 11 months ago
Modality-Agnostic Drug Discovery With Cullinan Oncology's Nadim Ahmed
We love to hear from our listeners. Send us a message.
Call it fortuitous, good planning, instinct, or a combination of all three, but Nadim Ahmed's …2 years, 11 months ago
Women In Biotech With Bill & Melinda Gates MRI's Piper Trelstad, Ph.D.
We love to hear from our listeners. Send us a message.
After more than 21 years leading process, product, and technical development efforts at Merck …
3 years ago